Literature DB >> 27769673

Not just an antibiotic target: Exploring the role of type I signal peptidase in bacterial virulence.

Shawn I Walsh1, Arryn Craney1, Floyd E Romesberg1.   

Abstract

The looming antibiotic crisis has prompted the development of new strategies towards fighting infection. Traditional antibiotics target bacterial processes essential for viability, whereas proposed antivirulence approaches rely on the inhibition of factors that are required only for the initiation and propagation of infection within a host. Although antivirulence compounds have yet to prove their efficacy in the clinic, bacterial signal peptidase I (SPase) represents an attractive target in that SPase inhibitors exhibit broad-spectrum antibiotic activity, but even at sub-MIC doses also impair the secretion of essential virulence factors. The potential consequences of SPase inhibition on bacterial virulence have not been thoroughly examined, and are explored within this review. In addition, we review growing evidence that SPase has relevant biological functions outside of mediating secretion, and discuss how the inhibition of these functions may be clinically significant. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antivirulence; Arylomycin; Protein translocation; SPase; Secretion

Mesh:

Substances:

Year:  2016        PMID: 27769673      PMCID: PMC5279723          DOI: 10.1016/j.bmc.2016.09.048

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  200 in total

1.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.

Authors:  A Krogh; B Larsson; G von Heijne; E L Sonnhammer
Journal:  J Mol Biol       Date:  2001-01-19       Impact factor: 5.469

Review 2.  Bacterial lipases from Pseudomonas: regulation of gene expression and mechanisms of secretion.

Authors:  F Rosenau; K Jaeger
Journal:  Biochimie       Date:  2000-11       Impact factor: 4.079

3.  Novel lipoglycopeptides as inhibitors of bacterial signal peptidase I.

Authors:  Palaniappan Kulanthaivel; Adam J Kreuzman; Mark A Strege; Matthew D Belvo; Tim A Smitka; Matthew Clemens; James R Swartling; Kristina L Minton; Feng Zheng; Eddie L Angleton; Deborah Mullen; Louis N Jungheim; Valentine J Klimkowski; Thalia I Nicas; Richard C Thompson; Sheng-Bin Peng
Journal:  J Biol Chem       Date:  2004-06-01       Impact factor: 5.157

4.  HxcQ liposecretin is self-piloted to the outer membrane by its N-terminal lipid anchor.

Authors:  Véronique Viarre; Eric Cascales; Geneviève Ball; Gérard P F Michel; Alain Filloux; Romé Voulhoux
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

Review 5.  The protein secretion systems in Listeria: inside out bacterial virulence.

Authors:  Mickaël Desvaux; Michel Hébraud
Journal:  FEMS Microbiol Rev       Date:  2006-09       Impact factor: 16.408

6.  Functional analysis of the Tsh autotransporter from an avian pathogenic Escherichia coli strain.

Authors:  Maria Kostakioti; Christos Stathopoulos
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli.

Authors:  D Bieber; S W Ramer; C Y Wu; W J Murray; T Tobe; R Fernandez; G K Schoolnik
Journal:  Science       Date:  1998-06-26       Impact factor: 47.728

8.  Interaction of fimbriated and nonfimbriated strains of unencapsulated Haemophilus influenzae with human respiratory tract mucus in vitro.

Authors:  W Barsum; R Wilson; R C Read; A Rutman; H C Todd; N Houdret; P Roussel; P J Cole
Journal:  Eur Respir J       Date:  1995-05       Impact factor: 16.671

Review 9.  Selective transport by SecA2: an expanding family of customized motor proteins.

Authors:  Barbara A Bensing; Ravin Seepersaud; Yihfen T Yen; Paul M Sullam
Journal:  Biochim Biophys Acta       Date:  2013-10-31

10.  Pet, an autotransporter enterotoxin from enteroaggregative Escherichia coli.

Authors:  C Eslava; F Navarro-García; J R Czeczulin; I R Henderson; A Cravioto; J P Nataro
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more
  5 in total

1.  Inhibition of Protein Secretion in Escherichia coli and Sub-MIC Effects of Arylomycin Antibiotics.

Authors:  Shawn I Walsh; David S Peters; Peter A Smith; Arryn Craney; Melissa M Dix; Benjamin F Cravatt; Floyd E Romesberg
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 2.  Regulatory mechanisms of sub-inhibitory levels antibiotics agent in bacterial virulence.

Authors:  Baobao Liu; Xiaojie Zhang; Xueyan Ding; Yang Wang; Guoqiang Zhu
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-24       Impact factor: 4.813

3.  A novel secretion and online-cleavage strategy for production of cecropin A in Escherichia coli.

Authors:  Meng Wang; Minhua Huang; Junjie Zhang; Yi Ma; Shan Li; Jufang Wang
Journal:  Sci Rep       Date:  2017-08-04       Impact factor: 4.379

4.  Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms.

Authors:  Philipp Le; Elena Kunold; Robert Macsics; Katharina Rox; Megan C Jennings; Ilke Ugur; Maria Reinecke; Diego Chaves-Moreno; Mathias W Hackl; Christian Fetzer; Franziska A M Mandl; Johannes Lehmann; Vadim S Korotkov; Stephan M Hacker; Bernhard Kuster; Iris Antes; Dietmar H Pieper; Manfred Rohde; William M Wuest; Eva Medina; Stephan A Sieber
Journal:  Nat Chem       Date:  2019-12-16       Impact factor: 24.427

5.  Involvement of signal peptidase I in Streptococcus sanguinis biofilm formation.

Authors:  Jessica Aynapudi; Fadi El-Rami; Xiuchun Ge; Victoria Stone; Bin Zhu; Todd Kitten; Ping Xu
Journal:  Microbiology (Reading)       Date:  2017-09-04       Impact factor: 2.777

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.